Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis

Optimal salvage therapy for refractory HLH is unknown. In our patient, ruxolitinib treatment led to clinical remission of refractory HLH.

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Broglie, Larisa, Pommert, Lauren, Rao, Sridhar, Thakar, Monica, Phelan, Rachel, Margolis, David, Talano, Julie
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Exceptional Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728466/
https://ncbi.nlm.nih.gov/pubmed/29296794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017007526
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados